In the past few years, the understanding of microRNA (miRNA) biogenesis, the molecular
mechanisms by which miRNAs regulate gene expression, and the functional roles of …

Parkinson's disease (PD) is the second most common neurodegenerative disease, affecting
the elderly worldwide and causing significant movement impairments. The goal of PD …

Parkinson's disease (PD) is the second-most common neurodegenerative disease, and its
pathophysiology is associated with alpha-synuclein accumulation, oxidative stress …

The prevalence of neurodegenerative disorders is rising steadily as human life expectancy
increases. However, limited knowledge of the molecular basis of disease pathogenesis is a …

Parkinson's disease is one of the most common human neurodegenerative disorders
caused by the loss of dopaminergic neurons from the substantia nigra pars compacta of …

Parkinson's disease (PD) is one of the most common neurodegenerative disorders that
manifest various motor and nonmotor symptoms. Although currently available therapies can …

The degeneration and dysfunction of neurons are key features of neurodegenerative
diseases (NDs). Currently, one of the main challenges facing researchers and clinicians is …

Parkinson's disease (PD) is a chronic, progressive neurodegenerative disease
characterized by both motor and nonmotor features. The diagnose of PD is based on a …

A group of circulating microRNAs (miRNAs) have been implicated in the pathogenesis of
Parkinson's disease. However, a comprehensive study of the interactions between …

Neurodegenerative diseases (NDDs) are the result of progressive deterioration of neurons,
ultimately leading to disabilities. There is no effective cure for NDDs at present; ongoing …